From Bryn's Economics Blog:
The decision by NICE to reject a liver cancer drug is explained here
http://news.bbc.co.uk/1/hi/health/8368023.stm
and the opposing view here
http://news.bbc.co.uk/1/hi/health/8367962.stm
and a personal view, here
http://news.bbc.co.uk/1/hi/health/8367715.stm
a) Discuss whether this drug should be licenced for use in the NHS
No comments:
Post a Comment